Rüdiger Müller

916 total citations
27 papers, 585 citations indexed

About

Rüdiger Müller is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Rüdiger Müller has authored 27 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 10 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Rüdiger Müller's work include Rheumatoid Arthritis Research and Therapies (14 papers), Biosimilars and Bioanalytical Methods (6 papers) and Systemic Lupus Erythematosus Research (6 papers). Rüdiger Müller is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Biosimilars and Bioanalytical Methods (6 papers) and Systemic Lupus Erythematosus Research (6 papers). Rüdiger Müller collaborates with scholars based in Switzerland, Germany and United States. Rüdiger Müller's co-authors include Almut Scherer, Christian Maihöfner, Frank Seifert, Elena Peltz, Stefan Lanz, Johannes von Kempis, Axel Finckh, Ahmed Sheriff, Adrian Ciurea and Birgit Vogt and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Vaccine.

In The Last Decade

Rüdiger Müller

26 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rüdiger Müller Switzerland 12 321 212 106 71 60 27 585
Tsivia Tauber Israel 14 116 0.4× 92 0.4× 120 1.1× 13 0.2× 62 1.0× 28 482
Michael E. Weiss United States 13 42 0.1× 248 1.2× 31 0.3× 119 1.7× 36 0.6× 20 813
Wolfgang Fuchs Germany 10 16 0.0× 69 0.3× 36 0.3× 33 0.5× 26 0.4× 13 276
Bóris Afonso Cruz Brazil 15 412 1.3× 102 0.5× 255 2.4× 33 0.5× 26 0.4× 38 668
Yoshifuji Matsumoto Japan 11 131 0.4× 77 0.4× 70 0.7× 55 0.8× 55 0.9× 26 444
O. L. Meyers South Africa 17 380 1.2× 273 1.3× 115 1.1× 30 0.4× 45 0.8× 43 893
W Stangel Germany 14 358 1.1× 218 1.0× 153 1.4× 22 0.3× 25 0.4× 42 839
E de Klerk Netherlands 7 481 1.5× 196 0.9× 148 1.4× 61 0.9× 13 0.2× 9 663
Ana María Santos Colombia 11 245 0.8× 109 0.5× 98 0.9× 28 0.4× 42 0.7× 54 389
Erhan Berber United States 5 62 0.2× 92 0.4× 40 0.4× 23 0.3× 39 0.7× 10 309

Countries citing papers authored by Rüdiger Müller

Since Specialization
Citations

This map shows the geographic impact of Rüdiger Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger Müller more than expected).

Fields of papers citing papers by Rüdiger Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüdiger Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger Müller. The network helps show where Rüdiger Müller may publish in the future.

Co-authorship network of co-authors of Rüdiger Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Rüdiger Müller. A scholar is included among the top collaborators of Rüdiger Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rüdiger Müller. Rüdiger Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kalweit, Gabriel, Ulrich A. Walker, Axel Finckh, et al.. (2021). Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network. PLoS ONE. 16(6). e0252289–e0252289. 26 indexed citations
3.
Amsler, Jennifer, Hendrik Schulze‐Koops, Thomas Hügle, et al.. (2021). AB0270 EFFECTIVENESS OF A SWITCH FROM TOFACITINIB TO BARICITINIB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA IN SWITZERLAND. Annals of the Rheumatic Diseases. 80. 1161–1161. 1 indexed citations
4.
Perrier, Clémentine, et al.. (2021). POS0668 REAL WORLD EFFECTIVENESS OF BARICITINIB IN THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM-RA). Annals of the Rheumatic Diseases. 80. 577–578. 8 indexed citations
5.
Schmid, Nathan, Adrian Ciurea, Cem Gabay, et al.. (2020). Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: A multi-centre, observational study. Travel Medicine and Infectious Disease. 38. 101818–101818.
6.
Burkhard, John-Patrik, Adrian Ciurea, Cem Gabay, et al.. (2020). Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals. Vaccine. 38(19). 3610–3617. 10 indexed citations
7.
8.
9.
Kempis, Johannes von, Rafael Sauter, Michael Schiff, et al.. (2018). Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. Journal of Clinical Medicine. 7(3). 57–57. 14 indexed citations
10.
Müller, Rüdiger, Johannes von Kempis, Sarah R. Haile, & Michael Schiff. (2015). Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort. Seminars in Arthritis and Rheumatism. 45(1). 28–34. 32 indexed citations
11.
Ciurea, Adrian, Almut Scherer, Ulrich Weber, et al.. (2015). Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis. Annals of the Rheumatic Diseases. 75(3). 532–539. 43 indexed citations
12.
Müller, Rüdiger, Christoph Renner, Cem Gabay, et al.. (2014). The advent of biosimilars: challenges and risks. Swiss Medical Weekly. 144(2728). w13980–w13980. 15 indexed citations
13.
Ciurea, Adrian, Almut Scherer, Pascale Exer, et al.. (2013). Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort. Arthritis & Rheumatism. 65(12). 3096–3106. 114 indexed citations
14.
Zeidler, Jan, Thomas Mittendorf, Rüdiger Müller, & Johannes von Kempis. (2012). Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective. Health Economics Review. 2(1). 20–20. 9 indexed citations
15.
Müller, Rüdiger, Birgit Vogt, Luis E. Muñoz, et al.. (2012). Detection of low level cryoglobulins by flow cytometry. Cytometry Part A. 81A(10). 883–887. 6 indexed citations
16.
Peltz, Elena, Frank Seifert, Stefan Lanz, Rüdiger Müller, & Christian Maihöfner. (2011). Impaired Hand Size Estimation in CRPS. Journal of Pain. 12(10). 1095–1101. 81 indexed citations
17.
Müller, Rüdiger & Thomas Reichmann. (2010). Rechnungswesen und Controlling: Integrierte Softwarelösungen für den Mittelstand. Controlling. 22(3). 204–206. 1 indexed citations
18.
Vogt, Birgit, et al.. (2007). CRP and the disposal of dying cells: Consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity. 40(4). 295–298. 43 indexed citations
19.
Panaretto, Kathryn S, et al.. (2002). Is being Aboriginal or Torres Strait Islander a risk factor for poor neonatal outcome in a tertiary referral unit in north Queensland?. Journal of Paediatrics and Child Health. 38(1). 16–22. 27 indexed citations
20.
Müller, Rüdiger, et al.. (2000). Functional and Structural Defects in HIV Type 1 nef Genes Derived from Pediatric Long-Term Survivors. AIDS Research and Human Retroviruses. 16(17). 1855–1868. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsivia Tauber Breakdown of academic impact, for papers by Michael E. Weiss Breakdown of academic impact, for papers by Wolfgang Fuchs Breakdown of academic impact, for papers by Bóris Afonso Cruz Breakdown of academic impact, for papers by Yoshifuji Matsumoto Breakdown of academic impact, for papers by O. L. Meyers Breakdown of academic impact, for papers by W Stangel Breakdown of academic impact, for papers by E de Klerk Breakdown of academic impact, for papers by Ana María Santos Breakdown of academic impact, for papers by Erhan Berber
Rankless by CCL
2026